Literature DB >> 24353901

Cyclophosphamide Induces an Early Wave of Acrolein-Independent Apoptosis in the Urothelium.

Francis M Hughes1, Alexa G Corn1, Andrew R Nimmich1, Jeffery D Pratt-Thomas1, J Todd Purves2.   

Abstract

PURPOSE: Hemorrhagic cystitis (HC or bladder inflammation) affects a significant number of patients undergoing cyclophosphamide (CP) chemotherapy despite treatment with 2-mercaptoethane sulfonate (Mesna) to inactivate the metabolite acrolein. While the mechanism is unknown, there is clearly acrolein-independent damage to the urothelium. In this study we have explored the induction of apoptosis in the urothelium as a marker of damage and the mechanism underlying the acrolein-independent apoptosis.
MATERIALS AND METHODS: Apoptosis in urothelium (caspase-3/7 activity and Poly (ADP-ribosyl) polymerase (PARP) cleavage) was measured following CP administration (80 mg/kg). Sodium 2-mercaptoethane sulfonate (Mesna) was used to mask acrolein's effect. An IL-1β receptor antagonist and a cell-permeable caspase-1 inhibitor were used to assess the involvement of IL-1β and caspase-1, respectively.
RESULTS: Two waves of apoptosis were detected following CP administration, one peaking at 2 h and a second at 48 h. The first wave was independent of acrolein. Caspase-1 was also active at 2 h and activation of caspase-3/7 was blocked by a caspase-1 inhibitor but not an IL-1β receptor antagonist suggesting the direct activation of caspase-3/7 by caspase-1 without the need for IL-1β as an intermediate.
CONCLUSIONS: Our results indicate that CP initiates an early, acrolein-independent wave of apoptosis that results from direct cleavage of caspase-3/7 by caspase-1.

Entities:  

Keywords:  Apoptosis; Bladder; Cyclophosphamide; Cystitis; Urothelium

Year:  2013        PMID: 24353901      PMCID: PMC3864667          DOI: 10.4236/abb.2013.48A2002

Source DB:  PubMed          Journal:  Adv Biosci Biotechnol


  28 in total

1.  Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction.

Authors:  Jacques-Antoine Haefliger; Pierre Tissières; Thomas Tawadros; Andrea Formenton; Jean-Louis Bény; Pascal Nicod; Peter Frey; Paolo Meda
Journal:  Exp Cell Res       Date:  2002-04-01       Impact factor: 3.905

Review 2.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

Review 3.  Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.

Authors:  M B Haselberger; T L Schwinghammer
Journal:  Ann Pharmacother       Date:  1995-09       Impact factor: 3.154

4.  Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

Authors:  L Li; W El-Kholy; C J Rhodes; P L Brubaker
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

5.  Phosphorylation of extracellular signal-regulated kinases in urinary bladder in rats with cyclophosphamide-induced cystitis.

Authors:  Kimberly A Corrow; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-04-04       Impact factor: 3.619

6.  Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats.

Authors:  Ozkan Kanat; E Kurt; U Yalcinkaya; T Evrensel; O Manavoglu
Journal:  Indian J Cancer       Date:  2006 Jan-Mar       Impact factor: 1.224

7.  BK-virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation.

Authors:  Orli Megged; Jeremiah Stein; David Ben-Meir; Lester M Shulman; Isaac Yaniv; Itamar Shalit; Itzhak Levy
Journal:  J Pediatr Hematol Oncol       Date:  2011-04       Impact factor: 1.289

Review 8.  Caspase-7: a protease involved in apoptosis and inflammation.

Authors:  Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Int J Biochem Cell Biol       Date:  2009-09-25       Impact factor: 5.085

Review 9.  Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation--a systematic review and evidence-based guidance for clinical management.

Authors:  Christian Harkensee; Nikhil Vasdev; Andrew R Gennery; Ian E Willetts; Clive Taylor
Journal:  Br J Haematol       Date:  2008-06-06       Impact factor: 6.998

10.  Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis.

Authors:  Lauren Arms; Beatrice M Girard; Margaret A Vizzard
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-23
View more
  6 in total

1.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

2.  The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction.

Authors:  Francis M Hughes; Hayden M Hill; Case M Wood; Andrew T Edmondson; Aliya Dumas; Wen-Chi Foo; James M Oelsen; Goran Rac; J Todd Purves
Journal:  J Urol       Date:  2015-12-18       Impact factor: 7.450

3.  Specialized pro-resolution mediators in the bladder: Receptor expression and recovery of bladder function from cystitis.

Authors:  Francis M Hughes; Armand Allkanjari; Michael R Odom; Huixia Jin; J Todd Purves
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-19

4.  Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice.

Authors:  Chi-Ping Huang; Chi-Cheng Chen; Yi-Tung Tsai; Chun-Chie Wu; Chih-Rong Shyr
Journal:  Cell Transplant       Date:  2019-01-24       Impact factor: 4.064

5.  Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Caitlin M Schaefer; Mehdi Nouraie; Justin T Tometich; Timothy W Hand; Carlton M Bates
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 5.770

6.  Shuanghuang Shengbai granule cures myelosuppression and suppresses lung cancer progression: mechanism and therapeutic targets from the aspect of microRNAs.

Authors:  Shuang Wang; Zhenye Xu; Lifang Wang
Journal:  Oncotarget       Date:  2017-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.